Pilar Manrique Ronquillo

Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018).

Pilar has worked over ten years studying the human gut microbiome. Her research has studied the role of human gut bacteriophages in health and disease and the impact of bacteriophages in the success of fecal microbiota transplant treatment. Moreover, during her postdoc at Ohio State University, she studied the influence of the gut microbiome on the recovery from central nervous system injury.

Pilar joins Microviable Therapeutics in 2022 as Research Scientist to support the R&D area.